BSE Live
Oct 29, 11:34Prev. Close
1120.05
Open Price
1097.65
Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
1097.65 (61545)
NSE Live
Dec 27, 11:22Prev. Close
-
Open Price
-
Bid Price (Qty.)
- (0)
Offer Price (Qty.)
- (0)
| Profit & Loss account of Titan Biotech (in Rs. Cr.) | Mar 25 | Mar 24 | Mar 23 | Mar 22 | Mar 21 | |
| 12 mths | 12 mths | 12 mths | 12 mths | 12 mths | ||
| INCOME | ||||||
| Revenue From Operations [Gross] | 156.45 | 164.07 | 144.00 | 152.81 | 142.24 | |
| Less: Excise/Sevice Tax/Other Levies | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Revenue From Operations [Net] | 156.45 | 164.07 | 144.00 | 152.81 | 142.24 | |
| Total Operating Revenues | 156.45 | 164.07 | 144.00 | 152.81 | 142.24 | |
| Other Income | 3.91 | 1.75 | 1.94 | 1.02 | 0.79 | |
| Total Revenue | 160.36 | 165.82 | 145.94 | 153.83 | 143.03 | |
| EXPENSES | ||||||
| Cost Of Materials Consumed | 75.48 | 80.89 | 70.81 | 75.48 | 67.30 | |
| Purchase Of Stock-In Trade | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Operating And Direct Expenses | 16.62 | 18.13 | 15.77 | 12.24 | 10.72 | |
| Changes In Inventories Of FGWIP And Stock In Trade | -2.85 | -5.29 | -0.93 | -0.60 | -2.73 | |
| Employee Benefit Expenses | 26.38 | 23.71 | 18.21 | 16.14 | 14.05 | |
| Finance Costs | 0.80 | 1.17 | 0.75 | 1.28 | 1.67 | |
| Depreciation And Amortisation Expenses | 4.17 | 3.33 | 2.60 | 2.54 | 2.22 | |
| Other Expenses | 15.39 | 12.34 | 10.63 | 8.56 | 6.77 | |
| Total Expenses | 136.00 | 134.29 | 117.83 | 115.63 | 100.00 | |
| Profit/Loss Before Exceptional, ExtraOrdinary Items And Tax | 24.37 | 31.53 | 28.12 | 38.20 | 43.03 | |
| Exceptional Items | 0.00 | 0.00 | 0.00 | 0.00 | -0.32 | |
| Profit/Loss Before Tax | 24.37 | 31.53 | 28.12 | 38.20 | 42.71 | |
| Tax Expenses-Continued Operations | ||||||
| Current Tax | 5.97 | 7.79 | 7.21 | 9.70 | 10.86 | |
| Less: MAT Credit Entitlement | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Deferred Tax | 0.12 | 0.11 | -0.09 | -0.07 | 0.14 | |
| Other Direct Taxes | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Total Tax Expenses | 6.10 | 7.87 | 7.09 | 9.65 | 11.00 | |
| Profit/Loss After Tax And Before ExtraOrdinary Items | 18.27 | 23.66 | 21.02 | 28.55 | 31.71 | |
| Profit/Loss From Continuing Operations | 18.27 | 23.66 | 21.02 | 28.55 | 31.71 | |
| Profit/Loss For The Period | 18.27 | 23.66 | 21.02 | 28.55 | 31.71 | |
| Minority Interest | 0.00 | 0.00 | 0.00 | 0.00 | -1.37 | |
| Consolidated Profit/Loss After MI And Associates | 21.53 | 24.85 | 24.84 | 28.74 | 30.34 | |
| OTHER ADDITIONAL INFORMATION | ||||||
| EARNINGS PER SHARE | ||||||
| Basic EPS (Rs.) | 26.00 | 30.00 | 25.00 | 31.00 | 37.00 | |
| Diluted EPS (Rs.) | 26.00 | 30.00 | 25.00 | 31.00 | 37.00 | |
| DIVIDEND AND DIVIDEND PERCENTAGE | ||||||
| Equity Share Dividend | 1.65 | 1.49 | 1.24 | 1.24 | 0.83 | |
| Tax On Dividend | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
03.06.2025
Titan Biotech Consolidated March 2025 Net Sales at Rs 35.17 crore, down 11.9% Y-o-Y
02.06.2025
Titan Biotech Standalone March 2025 Net Sales at Rs 35.17 crore, down 11.9% Y-o-Y
28.02.2025
Titan Biotech Consolidated December 2024 Net Sales at Rs 38.28 crore, down 16.75% Y-o-Y
17.02.2025
Titan Biotech Standalone December 2024 Net Sales at Rs 38.28 crore, down 16.75% Y-o-Y
03.06.2025
Titan Biotech Consolidated March 2025 Net Sales at Rs 35.17 crore, down 11.9% Y-o-Y
02.06.2025
Titan Biotech Standalone March 2025 Net Sales at Rs 35.17 crore, down 11.9% Y-o-Y
28.02.2025
Titan Biotech Consolidated December 2024 Net Sales at Rs 38.28 crore, down 16.75% Y-o-Y
17.02.2025
Titan Biotech Standalone December 2024 Net Sales at Rs 38.28 crore, down 16.75% Y-o-Y
15.02.2017
15.02.2017
14.02.2017
13.02.2017